Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury (Q44966048)

7 December 2017

Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury (English)

1 reference

7 December 2017

1 reference

1

1 reference

7 December 2017

8

Charles A Dinarello

1 reference

7 December 2017

Ignacio M Seropian

2

1 reference

7 December 2017

Eleonora Mezzaroma

3

1 reference

7 December 2017

Benjamin W Van Tassell

4

1 reference

7 December 2017

Fadi N Salloum

5

1 reference

7 December 2017

Eli C Lewis

6

1 reference

7 December 2017

Norbert Voelkel

7

1 reference

7 December 2017

Antonio Abbate

9

1 reference

7 December 2017

12 May 2011

1 reference

Journal of Molecular and Cellular Cardiology

7 December 2017

1 reference

7 December 2017

51

1 reference

7 December 2017

244-251

1 reference

7 December 2017

2

1 reference

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

The immune system and cardiac repair.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Clinical practice. Alpha1-antitrypsin deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by alpha1-antitrypsin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Alpha 1-antitrypsin in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Acute phase proteins in patients with acute coronary syndrome: Correlations with diagnosis, clinical features, and angiographic findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Inflammasomes: too big to miss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Proapoptotic effects of caspase-1/interleukin-converting enzyme dominate in myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

A role for caspase-1 in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

No-reflow: the next challenge in treatment of ST-elevation acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Myocardial no-reflow in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Coronary microembolization: from bedside to bench and back to bedside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Autoinflammatory diseases: an update of clinical and genetic aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.003

10.1016/J.YJMCC.2011.05.003

7 January 2021

Identifiers

DOI

1 reference

7 December 2017

1 reference